AAPS PharmSci 360
AI and computational psychiatry: Finding ‘hidden cues’
The pharmaceutical industry has increasingly been adopting artificial intelligence – which has demonstrated the ability to predict instances of schizophrenia with 74% accuracy.
Archives for November 16, 2018
AAPS PharmSci360
‘The rules of the game’: Applying first principles of engineering to manufacturing
Bernard McGarvey, formerly of Eli Lilly, spoke with us about first principles of engineering in pharma, following his keynote ‘Engineering First Principles Applications to Pharmaceutical Manufacturing.'